Suppr超能文献

在感染的第一个月期间,人类免疫缺陷病毒突变优先出现在已知的细胞毒性T淋巴细胞表位中。

Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes.

作者信息

Bernardin Flavien, Kong Denice, Peddada Lorraine, Baxter-Lowe Lee Ann, Delwart Eric

机构信息

Blood Systems Research Institute, San Francisco, CA 94118, USA.

出版信息

J Virol. 2005 Sep;79(17):11523-8. doi: 10.1128/JVI.79.17.11523-11528.2005.

Abstract

The full protein coding region of human immunodeficiency virus (HIV) genomes were sequenced using plasma collected from nine African-Americans prior to seroconversion and 7 to 28 days later. HIV mutations emerged in seven of these subjects at a genomewide rate of 2% per year. The location of nonsynonymous (NS) HIV mutations within these subjects was compared to their potential HLA-A and B types restricted CTL epitopes reported in the Los Alamos National Laboratory HIV immunology database. A statistically significant (P < 0.005) number of the early NS mutations (13.5%) were found within previously reported CTL epitopes. A virus sequencing and reported CTL epitopes database analysis therefore support a model where a significant proportion of very early nonsynonymous HIV mutations are selected by CTL.

摘要

利用从9名非裔美国人血清转化前及7至28天后采集的血浆,对人类免疫缺陷病毒(HIV)基因组的完整蛋白质编码区进行了测序。在这些受试者中,有7人出现了HIV突变,全基因组突变率为每年2%。将这些受试者体内非同义(NS)HIV突变的位置与其在洛斯阿拉莫斯国家实验室HIV免疫学数据库中报告的潜在HLA - A和B型限制性CTL表位进行了比较。在先前报告的CTL表位中发现了数量具有统计学意义(P < 0.005)的早期NS突变(13.5%)。因此,病毒测序和报告的CTL表位数据库分析支持了这样一种模型,即相当一部分非常早期的非同义HIV突变是由CTL选择的。

相似文献

引用本文的文献

3
The mutable vaccine for mutable viruses.针对可变病毒的可变疫苗。
Immunotherapy. 2017 Jun;9(8):659-667. doi: 10.2217/imt-2017-0030.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验